Latest Articles in DCGI approval
Akums Gets Fixed Drug Combination Approval From DCGI For Erectile Dysfunction
Tamsulosin is primarily used when an enlarged prostate impedes normal urine flow and bladder emptying. Conversely, Tadalafil's mechanism of action supports the development of a naturally induced erection, contingent upon sexual stimulation
Read More
Omicron-specific mRNA Booster From Gennova Gets DCGI Approval
The booster vaccine, Gemcovac-OM works against the Omicron variant of SARS-CoV-2 and has received emergency use authorization (EUA) from the regulatory authority
Read More
Indian Immunologicals Gets DCGI Approval For Measles-Rubella Vaccine
Measles is caused by a virus that lives in the nose and throat mucus of an infected person and spreads easily through breathing, coughing, and sneezing. There is no specific antiviral drug available to treat measles
Read More
Akums Receives DCGI Approval To Launch Diabetes Drug For Type 2 Diabetics
Akums Drugs and Pharmaceutical, an Indian contract drug manufacturing company (CDMO) has launched the novel antidiabetic drug ‘Lobeglitazone’, the drug is a new formulation manufactured specifically for type 2 diabetic patients by helping them improve pancreatic beta-cell function, the pharma compan
Read More
Samples Collected From Indian Firm Linked To Gambia Deaths Meet Required Standards
Gambia's Medicines Control Agency, a national regulatory body, later said it had not yet pinpointed the exact cause of the deaths
Read More
DCGI Approves SII’s Ebola Vaccine For Export To Uganda
Earlier, WHO had sought collaboration with ebola vaccines manufacturers for the prevention. The potential vaccine it has chosen for participation in a solidarity clinical trial in Uganda is ChAdOx1 biEBOV
Read More
DCGI Allows Serum Institute To Export Malaria Vaccine To Uk
The malaria vaccine was designed at the Jenner Institute, University of Oxford, in collaboration with the SII as manufacturer to develop the jab for large-scale supply
Read More
DCGI Clears AstraZeneca’s Lynparza Drug For Breast Cancer
The approval was based on results from the OlympiA Phase III trial, which suggested that Olaparib demonstrated a statistically significant and clinically meaningful improvement, with an overall survival benefit
Read More
Bharat Biotech Hopeful To Get Regulator's Nod For Intranasal Covid Vaccine
The Drug Controller General of India gave its nod to conduct clinical trials for BBIL's intranasal vaccine as booster dose. Separately, the DCGI also granted permission to the firm to conduct phase-3 clinical trial to compare the immunogenecity and safety of BBV-154 (intranasal) with Covaxin. This t
Read More